Take your business to the next level. Explore the latest trends and actionable insights to inform business strategy and pinpoint opportunities and risks.

Netherlands: Job Trends in the Pharmaceuticals and Healthcare Sector (October 2023 - January 2024)

  • The number of active job postings in the Pharmaceuticals and Healthcare sector of Netherlands decreased by 9.43% MoM, and decreased by 5.88% since October 2023, reaching 1,008 active job postings in January 2024.

  • A total of 332 new jobs were posted in January 2024, witnessing a decrease of 18.02% as compared to the previous month. On the other hand, 437 jobs were closed in the same month implying that companies took out 10.08% more jobs than the month earlier. For the period from October 2023 to January 2024, the number of new jobs posted decreased by 7.52% and the number of jobs closed increased by 10.35%

  • In terms of Compound Monthly Growth Rate (CMGR) between October 2023 and January 2024, the number of new jobs posted observed a negative growth rate of 2.57%, the number of active job postings observed a negative growth rate of 2% and the number of jobs closed observed a growth rate of 3.34%. Between October 2023 and January 2024, the average number of jobs posted stood at 383, number of jobs closed stood at 408 and number of active jobs stood at 1,074.

Netherlands: Job Trends in the Pharmaceuticals and Healthcare Sector (October 2023 - January 2024)

Published: September 2022
Source: GlobalData

Related Companies

Optum Inc

United States of America

Optum Inc
Evernorth Health Inc

United States of America

Evernorth Health Inc
Johnson & Johnson

United States of America

HCA Healthcare Inc

United States of America

Eli Lilly and Co

United States of America

Merck & Co Inc

United States of America

Pfizer Inc

United States of America

AbbVie Inc

United States of America

Sanofi

France

Still looking?

Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.

Explorer

Access more premium companies when you subscribe to Explorer